GEM AROMATICS LIMITED
GEMAROMA · General/Diversified · NSE
₹174
Current Market Price
Fair Value (DCF)
₹91
Margin of Safety
-47.4%
Updated 1d ago
YieldIQ Score
38/100
Piotroski F-Score
4/9
Economic Moat
Narrow
Confidence
41%
ROE
—
Debt/Equity
0.32
WACC
11.1%
Market Cap
₹907 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
23.3%
Return on capital employed
EV / EBITDA
15.0×
Enterprise multiple
Debt / EBITDA
3.6×
Leverage vs earnings
Interest Coverage
10.5×
EBIT covers interest
Current Ratio
1.91×
Short-term liquidity
Asset Turnover
0.93×
Revenue per ₹ of assets
Revenue CAGR (3Y)
16.7%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹173.71
Bear case
₹47.04
MoS -269.3%
Base case
₹91.39
MoS -90.1%
Bull case
₹127.69
MoS -36.0%
Ratio Trends
GEMAROMA · last 4 annual periods
ROE
18.8%
ROCE
17.7%
Operating Margin
—
Debt / Equity
0.79×
PE
—
EV / EBITDA
—
Historical Financials
GEMAROMA · Annual, last 4 years· amounts in ₹Cr unless noted
| Metric | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | ₹311 Cr | ₹419 Cr | ₹446 Cr | ₹495 Cr | +16.7% |
| EBITDA | ₹51.4 Cr | ₹65.9 Cr | ₹79.9 Cr | ₹89.9 Cr | +20.5% |
| EBIT | — | — | — | — | — |
| PAT | ₹31.2 Cr | ₹44.7 Cr | ₹50.1 Cr | ₹53.4 Cr | +19.6% |
| EPS (diluted) | — | — | — | — | — |
| CFO | ₹-5.2 Cr | ₹15.3 Cr | ₹40.1 Cr | ₹-24.9 Cr | — |
| CapEx | ₹-14.2 Cr | ₹-14.4 Cr | ₹-39.1 Cr | ₹-105 Cr | — |
| FCF | ₹-19.4 Cr | ₹0.9 Cr | ₹1.0 Cr | ₹-130 Cr | — |
| Total Assets | ₹240 Cr | ₹296 Cr | ₹369 Cr | ₹535 Cr | +30.7% |
| Total Debt | ₹78.1 Cr | ₹90.2 Cr | ₹112 Cr | ₹225 Cr | +42.2% |
| Shareholders' Equity | ₹138 Cr | ₹180 Cr | ₹231 Cr | ₹284 Cr | +27.1% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
GEMAROMA vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| AMNPLST AMNPLST | — | — | Pending | 15.9% | — |
| SRHHYPOLTD SRHHYPOLTD | — | — | Pending | 9.7% | — |
| INDOAMIN INDOAMIN | — | — | Pending | 17.4% | — |
| INDOBORAX INDOBORAX | — | — | Pending | 12.7% | — |
| VALIANTORG VALIANTORG | — | — | Pending | -0.5% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for GEMAROMA in the last 10 years.
AI Analysis Summary
GEM AROMATICS LIMITED appears overvalued by 47.4%, with a standout strength in its 16.7% 3-year revenue CAGR, but a concern is its narrow moat.
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of GEMAROMA →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for GEMAROMA →
Compare
Head-to-head with peers
Compare GEMAROMA side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse GEMAROMANow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.